Olaf Koch
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 2
- Co-authors
- Matthias Volkenandt (8 shared papers)Wolfgang E. Berdel (3 shared papers)Achim Heinecke (2 shared papers)Joseph R. Bertino (6 shared papers)Jens Atzpodien (4 shared papers)Carsten Müller‐Tidow (5 shared papers)J. van de Loo (2 shared papers)Cristina Sauerland (1 shared paper)
- Journals
- British Journal of Haematology (2 papers)Leukemia Research (2 papers)Blood (2 papers)The Annals of Thoracic Surgery (1 paper)Journal of Cutaneous Pathology (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Olaf Koch
35 papers receiving 446 citations
Peers
Comparison fields: 5 of 70
- Hematology 154
- Dermatology 85
- Chemical Health and Safety 5
- Oncology 203
- Pathology and Forensic Medicine 105
Countries citing papers authored by Olaf Koch
This map shows the geographic impact of Olaf Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Koch more than expected).
Fields of papers citing papers by Olaf Koch
This network shows the impact of papers produced by Olaf Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Koch. The network helps show where Olaf Koch may publish in the future.
Co-authors
The 25 scholars most cited alongside Olaf Koch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 96 | |
| 2 | 2002 | 52 | |
| 3 | 1999 | 40 | |
| 4 | 2000 | 27 | |
| 5 | 1993 | 26 | |
| 6 | 2012 | 25 | |
| 7 | 1992 | 23 | |
| 8 | 2006 | 20 | |
| 9 | 1993 | 19 | |
| 10 | 1993 | 17 | |
| 11 | 2014 | 16 | |
| 12 | 1993 | 11 | |
| 13 | 2002 | 11 | |
| 14 | 1988 | 9 | |
| 15 | 2003 | 8 | |
| 16 | 2003 | 6 | |
| 17 | 1979 | 6 | |
| 18 | Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia. | 1993 | 6 |
| 19 | 1992 | 5 | |
| 20 | 1998 | 5 |
About Olaf Koch
Olaf Koch is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Dermatology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 469 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Cutaneous lymphoproliferative disorders research (5 papers), Lung Cancer Treatments and Mutations (4 papers), Immune Cell Function and Interaction (3 papers), Cancer Treatment and Pharmacology (2 papers), Genetic factors in colorectal cancer (2 papers), Acute Myeloid Leukemia Research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (154 citations), Dermatology (85 citations), Chemical Health and Safety (5 citations), Oncology (203 citations) and Pathology and Forensic Medicine (105 citations). Olaf Koch has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Matthias Volkenandt, Wolfgang E. Berdel, Achim Heinecke, Joseph R. Bertino, Jens Atzpodien, Carsten Müller‐Tidow, J. van de Loo, Cristina Sauerland, Thomas Büchner and Andrea Schumacher. Their work appears in journals such as British Journal of Haematology, Leukemia Research, Blood, The Annals of Thoracic Surgery and Journal of Cutaneous Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.